Let’s share care with the world
Improve access, performance, and accountability with specialised logistics for the Pharmaceutical and Healthcare industry.
In a global economy where cross-border trade contributes to 50% of GDP, the Covid-19 pandemic has had an irreversible impact on supply chains. For months, it has put ‘essential’ Pharmaceutical and Healthcare logistics teams through a stress test unlike any other the modern world has experienced. In doing so, it has accelerated the need to reassess all moving parts, from factory to pharmacy, sparking what we call the ‘end-to-end innovation’ of Pharmaceutical and Healthcare logistics.
Pharma supply chains in a post-Covid-19 world will consist of resilient systems and processes infused with reliability, transparency and intelligence, at every stage.
Six trends shaping Pharma logistics
The antidote to your challenges
The Pharmaceutical industry is in the midst of enormous change. As the world’s population ages, providing people easy access to healthcare and medication has become a key responsibility. Precision medicine, customised to the needs of a single patient, is gaining momentum. Big brands are fighting the problem of counterfeit drugs, compounded by the rise of online retailers. And companies around the world are riding the wave of consolidation with mergers and acquisitions.
These changes add new layers of complexity to Pharma supply chains that are themselves seeking transformation. The ideal logistics partner is no longer the local provider, but a global player who can respond to demand, provide structural flexibility, ensure overall visibility, constantly improve results, and very importantly, build risk-based models.
That’s why we’ve built a team dedicated to Pharma logistics. A team of experts that:
- Understands the intricacies of the Pharma ecosystem
- Has the technical expertise and ‘visibility’ data required to support the industry’s efforts to standardise and follow best practices
- Uses digital platforms to provide reliable data and a single truth to all stakeholders
- Plans for the unexpected, reduces waste, cuts costs, and improves delivery times
- Builds a culture of continuous improvement for your supply chain
Manage, connect, simplify
Connecting supply chains in new ways for pharma and healthcare
In twenty years, when we look back on the evolution of global supply chains, people will see two very distinct periods – pre-COVID-19 and post-COVID-19. Yes, there have been viruses before, but none in our modern, globalised world, where cross-border trade comprises 50% of GDP. We have never had a supply chain that contains so many moving parts across so many countries with so many stakeholders involved. And that supply chain has never been put under the pressure it has recently, unless you count the theoretical exercises or disaster plans of academics and risk-managers.
In areas like pharmaceuticals and healthcare, professionals are balancing this need for reactive response with designing a more reliable, transparent, intelligent future for their supply chains. To effect change, these businesses need to assess the entire chain, from manufacture to delivery, to customs, to storage, to end customer.
Maximising the positive impact of the Covid-19 vaccine
The Pharmaceutical industry has worked tirelessly to do what usually takes 5-10 years, in a mere 10 months. To ensure that the effectiveness of the approved Covid-19 vaccines reach every corner of the world, we’ve reimagined our network, infrastructure, expertise, and technology like never before.
Handling a new reality
Despite congestion and limited capacity at Chinese and European airports, Hartmann International delivered six million masks from China to Germany when healthcare providers needed them most.